Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
Opus Genetics will be added to the Russell 3000, Russell 2000 and Russell Microcap Indexes effective June 29, 2026, as part of the quarterly reconstitution. CEO George Magrath noted that inclusion validates the company's progress in advancing gene therapies for inherited retinal diseases and enhances visibility within the investment community.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.